Elsevier

Preventive Medicine

Volume 19, Issue 2, March 1990, Pages 190-197
Preventive Medicine

A review of the use of saliva cotinine as a marker of tobacco smoke exposure

https://doi.org/10.1016/0091-7435(90)90020-KGet rights and content

Abstract

Cotinine, the major metabolite of nicotine, is a useful marker of exposure to tobacco smoke. It can be measured in plasma, urine, or saliva. However, distinguishing between active and passive smoking on the basis of a cotinine measurement may be difficult. In order to evaluate the relationship between saliva cotinine concentration and self-reported tobacco smoke exposure in both active and passive smokers, an English-language literature search using MEDLINE was conducted (1973–1989), and the bibliographies of identified articles were reviewed. Of 43 originally identified articles, only 22 met the criteria for inclusion. Specific information regarding population studied, reported tobacco smoke exposure, method of measurement, and cotinine concentrations was assessed. Passive smokers usually have cotinine concentrations in saliva below 5 ng/ml, but heavy passive exposure can result in levels ⩾10 ng/ml. Levels between 10 and 100 ng/ml may result from infrequent active smoking or regular active smoking with low nicotine intake. Levels >100 ng/ml are probably the result of regular active smoking. Four categorizations of tobacco smoke exposure are suggested on the basis of saliva cotinine concentrations.

References (45)

  • NL Benowitz

    The use of biologic fluid samples in assessing tobacco smoke consumption

  • International Agency for Research on Cancer

    Tobacco Smoking

  • National Research Council, Committee on Passive Smoking

    Environmental Tobacco Smoke: Measuring Exposures and Assessing Health Effects

    (1986)
  • U.S. Department of Health and Human Services

    The health consequences of involuntary smoking: A report of the Surgeon General

  • JJ Langone et al.

    Nicotine and its metabolites: Radioimmunoassays for nicotine and cotinine

    Biochemistry

    (1973)
  • NL Benowitz et al.

    Cotinine disposition and effects

    Clin Pharmacol Ther

    (1983)
  • DA Machacek et al.

    Quantification of cotinine in plasma and saliva by liquid chromatography

    Clin Chem

    (1986)
  • JJ Langone et al.

    Quantitation of cotinine in sera of smokers

    Res Commun Chem Pathol Pharmacol

    (1975)
  • EN Pattishall et al.

    Serum cotinine as a measure of tobacco smoke exposure in children

    Am J Dis Child

    (1985)
  • CL Williams et al.

    Validation of students' self-reported cigarette smoking status with plasma cotinine levels

    Am J Public Health

    (1979)
  • RA Greenberg et al.

    Measuring the exposure of infants to tobacco smoke

    N Engl J Med

    (1984)
  • S Matsukura et al.

    Effects of environmental tobacco smoke on urinary cotinine excretion in nonsmokers

    N Engl J Med

    (1984)
  • Cited by (206)

    • Changes in the salivary cotinine cut-offs to discriminate smokers and non-smokers before and after Spanish smoke-free legislation

      2022, Cancer Epidemiology
      Citation Excerpt :

      Similar studies indicate that the cut-off point for distinguishing between smokers and non-smokers have decreased in the last decades, coinciding with the implementation of tobacco control legislation [12,19–24]. We had previously estimated the salivary cotinine cut-off in 2005 to be 9.2 ng/mL, much lower than the ones estimated in the general population of other countries [11,12,19–24]; however, this cut-off point was calculated before the implementation of the new smoke-free legislation. In this study, we show that the general cotinine cut-off point in the population of Barcelona has decreased from 9.2 to 5.6 ng/mL after the implementation of the new legislation.

    • Overview of cotinine cutoff values for smoking status classification

      2019, Neuroscience of Nicotine: Mechanisms and Treatment
    View all citing articles on Scopus
    View full text